Site Search
Search Results
Smoke-Free Policies: Good For Business
... shown that there is no risk-free level of exposure to secondhand smoke (SHS). Smoke-free laws and policies provide immediate and long-term health benefits for both people who smoke and those who do not and are good for businesses and workers. Fact: Smoke-free Laws Do Not Negatively ... laws have found that these laws do not hurt, and may even benefit, restaurant sales. A report by the National Cancer Institute and the World Health Organization concluded that “smoke-free policies do not have negative economic consequences for businesses, including restaurants and ... and preventing 45,000 premature deaths. These declines in smoking and related disease saved over $500 million annually in tobacco-related health care costs, part of which would have been incurred by local businesses. [lxvi] , [lxvii] ACS CAN’s Position on Smoke-free Laws Research ...
Utilization Management in Breast Cancer and Hepatocellular Carcinoma
Executive Summary Utilization management (UM) refers to a variety of practices that health plans and pharmacy benefit managers employ to confirm the use of specific drugs or services aligns with the payer’s policy. Plans can use ... necessary, or to limit utilization of high-priced, specialty medications. UM use in oncology may have unintended consequences to patient care, such as delaying patient access to medication or increased administrative burden for the patient and provider. Prior to 2019, Medicare ...
Understanding Biologic and Biosimilar Drugs
... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional. Biologics have been a part of medical treatment for a long time and have ... one, some, or all of the conditions of the reference product. While the safety of a biosimilar is assured through FDA review and approval, your health care provider should review the product label for any prescribed biosimilar. Why biosimilars were introduced Biosimilars were introduced ... to you by your healthcare provider. This might be for several reasons, including that the biosimilar is the preferred product of your doctor or health plan. This preference might also come from physician’s experience with the product, a desire by your health plan to control costs, or ...
Survivor Views on the Composition of Clinical Trials
... to the composition of clinical trials. Four-in-five (79%) say it is important that a drug they are prescribed has been tested in people whose health is similar to theirs, with 57% saying this is very important and 22% somewhat important. Similarly, 76% agree that it is important the drug ... important that a drug is tested in patients who share their gender. Nationality, race, and ethnicity are viewed as somewhat less important than health condition, age, and gender when it comes to trial diversity, though still important. Fifty-seven percent say it is important the drug has ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...
The Risks of Secondhand Smoke in Casinos
... was hurting me so badly that I was struggling to breathe.” – Alecia Sibio, Former Casino Worker xvi Secondhand Smoke: Risking Workers’ Health Casino workers are at higher risk of exposure to SHS and therefore SHS-related illness than other workers: The National Institute of Occupational Safety and Health (NIOSH) and the U.S. Surgeon General found that occupational exposure to SHS increases workers’ risk of lung cancer and other diseases. ... Smoking at Hire as a Predictor of Employment Outcome. JOEM 38(9): 928-933. [xlv] Penner M and Penner S (1990). Excess Insured Health Care Costs from Tobacco-Using Employees in a Large Group Plan. JOEM 32(6): 521-523. The Risks of Secondhand Smoke in Casinos ...
Patient Assistance Programs
... Federal Anti-Kickback statutes, manufacturers are prohibited from directly paying for any part of drug costs for patients relying on a Federal Health Care Program (FHCP) including Medicare and veterans’ programs and having those costs count towards the patient’s out-of-pocket costs.1 ... companies. These programs are permitted to support FHCP patients, on the condition they operate within the parameters defined by the U.S. Health and Human Services Office of Inspector General. Requirements for eligibility in the programs vary: some programs only assist uninsured ...
Comments from ACS & ACS CAN on Topics and Scientific Questions for the 2025-2030 Dietary Guidelines for Americans
... Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN). The American Cancer Society is the nation’s largest voluntary health organization, dedicated to eliminating cancer as a major health outcome through research, education, and service. ACS CAN is the non-profit, non-partisan advocacy affiliate of the society. ACS CAN ... behaviors. Like the ACS guideline, the DGA must be an evidence-based path forward for individuals, families, schools, communities, health care professionals and policymakers to achieve and protect health through diet. Recommendations Red and Processed Meat: HHS and USDA should ...
Survivor Views on Social Connection & Isolation
... at least some of the time, a number similar to recent national surveys. Numerous studies describe the link between social isolation and negative health outcomes, [1] and a 2023 study by the American Cancer Society identifies an increased mortality risk among cancer survivors with higher ... reporting this impacted their connections a great deal. Other factors impacting social connection include stress, depression, or other mental health concerns (50%), missing or stopping work (45%), and those in their social circles feeling scared to talk to them, not knowing what to say, ... times to tell my loved ones because I didn't want to burden them, but then they would tell me it would not burden them, it would help them take care of me better.” “Teaching caregivers/supporters good questions to ask, things not to say, or how to just hang out in silence.” ...
Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment
... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...
Survivor Views of Pharmacogenomic Testing
... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...
Type
- (-) Remove Resource filter Resource
Priority Issue
State
Policy Issue
- Access to Health Care (28) Apply Access to Health Care filter
- Prevention and Early Detection (11) Apply Prevention and Early Detection filter
- Health Equity (10) Apply Health Equity filter
- Patient Quality of Life (10) Apply Patient Quality of Life filter
- Research, Funding and Drug Development (4) Apply Research, Funding and Drug Development filter